KMT2A and leukemia: This subgroup of leukemia exhibits a particular poor outcome, especially in infant.3,4 To date, 135 KMT2A rearrangements have been described; these chromosomal rearrangements give rise to oncofusion proteins that impair the differentiation of hematopoietic stem cells (HSCs) by epigenetic reprogramming.5–9